Associations between immune depression and cardiovascular events in HIV infection

AIDS

Volumn 27, Issue 17, 2013, Pages 2735-2748

  Sabin, Caroline A ^a   Ryom, Lene ^b   Wit, Stephane De ^c   Mocroft, Amanda ^a   Phillips, Andrew N ^a   Worm, Signe W ^b   Weber, Rainer ^d   Monforte, Antonella D'arminio ^e   Reiss, Peter ^f   Kamara, David ^a   El Sadr, Wafaa ^g   Pradier, Christian ^h   Dabis, Francois ^i,j   Law, Matthew ^k   Lundgren, Jens ^b,l  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF MILAN   (Italy)

^f STICHTING HIV MONITORING   (Netherlands)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ INSERM   (France)

^j UNIVERSITÉ DE BORDEAUX   (France)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

^l Rigshospitalet   (Denmark)

more..

Author keywords

Bias; Cardiovascular disease; CD4+ lymphocyte count; Myocardial infarction; Stroke

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84888304272     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000432457.91228.f3     Document Type: Conference Paper

References (38)

1. Triant VA, Regan S, Lee H, Sax PE, Beigs JB, Grinspoon SK. Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system. J Acquir Immune Defic Syndr 2010; 55:615-619.
2. Rasmussen LD, Engsig FN, Christensen H, Gerstoft J, Kronborg G, Pedersen C, et al. Risk of cerebrovascular events in persons with and without HIV: A Danish nationwide population-based cohort study. AIDS 2011; 25:1637-1646.
3. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, Tedaldi EM, et al. Low CD4R T cell count is a risk factor for cardiovascular disease events in the HIV Outpatient Study. Clin Infect Dis 2010; 51:435-447.
4. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22:2409-2418.
5. The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356:1723-1735.
6. Chow F, Regan S, Feske S, Meigs J, Grinspoon S, Triant V. HIV is an independent risk factor for ischemic stroke in a US healthcare system. Poster 820. 19th Conference on Retroviruses and Opportunistic Infections, Seattle; 5-8 March 2012.
7. Phillips AN, Carr A, Neuhaus J, Visnegarwaa F, Prineas R, Burman WJ, et al. Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther 2008; 13:177-187.
8. Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, et al. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis 2012; 55:600-607.
9. Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, et al. Traditional risk factors and D-dimer predict incidence cardiovascular disease events in chronic HIV infection. AIDS 2010; 24:1509-1517.
10. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection J Acquir Immune Defic Syndr 2002; 30:471-477.
11. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-2512.
12. Chahine LM, Khoriaty RN, Tomford WJ, Hussain MS. The changing face of neurosyphilis. Int J Stroke 2011; 6:136-143.
13. De Giorgi A, Fabbian F, Pala M, Bonetti F, Babini I, Bagnaresi I, et al. Cocaine and acute vascular diseases. Curr Drug Abuse Rev 2012; 5:129-134.
14. Yeung M, Bhalla A, Birns J. Recreational drug misuse and stroke. Curr Drug Abuse Rev 2011; 4:286-291.
15. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pamak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-612.
16. Friis-Møller N, Sabin CA, Weber R, dArminio Monforte A, El-Sadr WM, Reiss P, et al., The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. New Engl J Med 2003; 349:1993-2003.
17. dArminio Monforte A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, et al., The Writing Committee of the D:A:D Study Group. Cardio-and cerebrovascular events in HIV-infected persons. AIDS 2004; 18:1811-1817.
18. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011; 6:e16103.
19. Crane H, Paramsothy P, Heckbert S, Budoff M, Willig J, Mugavero M, et al. Primary vs. secondary MI events among HIVR individuals: the CNICS Cohort. Poster 821. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, 5-8 March 2012.
20. Triant VA. HIV infection and coronary heart disease: An intersection of epidemics. J Infect Dis 2012; 205 (Suppl 3):S355-S361.
21. Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795.
22. Baker J, Ayenew W, Quick H, Huppler Hullsiek K, Tracy R, Henry K, et al. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis 2010; 201:285-292.
23. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009; 51:268-273.
24. Protopopescu C, Dupon M, Hardel L, Rabaud C, Salmon D, Couturier F, et al. CD4R cell count >200 cells/mm3 and moderate alcohol consumption in HIV-positive patients over 11 years of antiretroviral therapy: evidence of protection against coronary and other arterial disease events. Abstract THPE082. XIX International AIDS Conference, Washington DC, US, 22-27 July 2012.
25. Squillace N, Zona S, Stentarelli C, Orlando G, Beghetto B, Nardini G, et al. Detectable HIV viral load is associated with metabolic syndrome. J Acquir Immune Defic Syndr 2009; 52:459-464.
26. Hansen BR, Petersen J, Haugaard SB, Madsbad S, Obel N, Suzuki Y, et al. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Med 2009; 10:378-387.
27. Alencastro PR, Fuchs SC, Wolff FH, Ikeda ML, Brandao ABM, Barcellos NT. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDS 2011; 25:627-634.
28. Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Bidwell Goetz M, et al. HIV infection and the risk of diabetes mellitus. AIDS 2009; 23:1227-1234.
29. Lo YC, Chen MY, Sheng WH, Hsieh SM, Sun HY, Liu WC, et al. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: A case-control study. HIV Med 2009; 10:302-309.
30. Guaraldi G, Zona S, Alexopoulos N, Orlando G, Carli F, Ligabue G, et al. Coronary aging in HIV-infected patients. Clin Infect Dis 2009; 49:1756-1762.
31. El-Sadr WM, Mullin CM, Carr A, Gibert C, Rappoport C, Visnegarwala F, et al. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-nave cohort. HIV Med 2005; 6:114-121.
32. Ho JE, Deeks SG, Hecht FM, Xie Y, Schnell A, Martin JN, et al. Initiation of antiretroviral therapy at higher nadir CD4R T-cell counts is associated with reduced arterial stiffness in HIVinfected individuals. AIDS 2010; 24:1897-1905.
33. de Saint Martin L, Pasquier E, Vandhuick O, Arnaud B, Vallet S, Duchemin J, et al. Correlations between carotid IMT, factor VIII activity level and metabolic disturbances: A cardio-vascular risk factor in the HIV positive persons. Curr HIV Res 2007; 5:361-364.
34. Ho JE, Scherzer R, Hecht FM, Maka K, Selby V, Martin JN, et al. The association of CD4R T-cell counts and cardiovascular risk in treated HIV disease. AIDS 2012; 26:1115-1120.
35. Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, et al. Low CD4R T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008; 22:1615-1624.
36. Mangili A, Polak JF, Skinner SC, Gerrior J, Sheehan H, Harrington A, et al. HIV infection and progression of carotid and coronary atherosclerosis: the CARE Study. J Acquir Immune Defic Syndr 2011; 58:148-153.
37. Vinikook M, Napravnik S, Floris-Moore M, Eron J. Incidence and clinical features of cerebrovascular events in HIV-positive adults in the southeastern United States. Abstract THPE092. XIX International AIDS Conference, Washington DC, USA, 22-27 July 2012.
38. Chapman JR. Clinical renal transplantation: where are we now, what are our key challenges. Transplant Proc2010; 42 (9 Suppl): S3-6.